An assessment of the design and dissemination of phase I clinical trials: where can we improve?

被引：0
|
作者：
Copsey, Bethan [1 ]
Odutayo, Ayodele [2 ]
Cook, Jonathan [2 ]
Dutton, Susan [2 ]
Altman, Douglas [2 ]
Hopewell, Sally [2 ]
机构：
[1] Univ Oxford, Oxford, England
[2] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England
来源：
TRIALS | 2017年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
P220
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Isotonic Design for Phase I Clinical Trials: Can We Improve Further?
    Alam, M. Iftakhar
    Sultana, Jafrin
    AUSTRIAN JOURNAL OF STATISTICS, 2019, 48 (05) : 34 - 44
  • [2] How can we improve clinical trials?
    Kaplan, Richard S.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2007, 4 (04): : 206 - 207
  • [3] How can we improve clinical trials?
    Richard S Kaplan
    Nature Clinical Practice Oncology, 2007, 4 : 206 - 207
  • [4] Clinical trials with endothelin receptor antagonists: What went wrong and where can we improve?
    Kohan, Donald E.
    Cleland, John G.
    Rubin, Lewis J.
    Theodorescu, Dan
    Barton, Matthias
    LIFE SCIENCES, 2012, 91 (13-14) : 528 - 539
  • [5] Clinical Trials in Portugal: How Can we Improve?
    Carvalho, Marta
    Cunha De Eca, Rita
    Gomes, Isabel
    Goncalves, Monica
    Lopes, Ana
    Lopes, Dina
    Maia, Joana
    Oliveira, Ana Marta
    Noronha, Ana
    Oliveira, Catarina Resende
    ACTA MEDICA PORTUGUESA, 2021, 34 (02): : 80 - 83
  • [6] Evaluation of assessment marks in the clinical years of an undergraduate medical training programme: Where are we and how can we improve?
    Brits, H.
    Joubert, G.
    Bezuidenhout, J.
    van der Merwe, L.
    AFRICAN JOURNAL OF HEALTH PROFESSIONS EDUCATION, 2021, 13 (04): : 222 - 228
  • [7] Using electronic health records for clinical trials: Where do we stand and where can we go?
    Mc Cord, Kimberly A.
    Hemkens, Lars G.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (05) : E128 - E133
  • [8] NOT and fracture mechanics. How can we improve failure assessment by NDT? Where we are - where do we go?
    Dobmann, G.
    Cioclov, D. D.
    Kurz, J. H.
    INSIGHT, 2011, 53 (12) : 668 - 672
  • [9] How can we improve clinical trials in amyotrophic lateral sclerosis?
    Gordon, Paul H.
    Meininger, Vincent
    NATURE REVIEWS NEUROLOGY, 2011, 7 (11) : 650 - 654
  • [10] How can we improve clinical trials in amyotrophic lateral sclerosis?
    Paul H. Gordon
    Vincent Meininger
    Nature Reviews Neurology, 2011, 7 : 650 - 654
12345